Simply create an account or log in to receive FREE 2-day shipping for all online U.S. orders. ORDER NOW
JULY 14, 2021—CHICAGO— Coapt, a leader in human-machine interface technology and medical device innovation, today announced its acquisition of Boston-based Liberating Technologies, Inc. (LTI). With the addition of LTI from College Park Industries, Coapt will increase its robust research and development capabilities and accelerate its development of cutting-edge technologies in the orthotics and prosthetics field.
Blair Lock, CEO of Coapt:
“Coapt has helped people with limb loss and limb difference live in a modern and independent way through advanced prosthetic technology. The acquisition of LTI amplifies Coapt's vision: to create extraordinary human-machine interfaces that benefit humans.”
LTI is an upper-limb prosthetics pioneer and research and development hub. The LTI team has received research funding support from the Department of Defense; the National Institutes of Health; the National Institute of Disability, Independent Living and Rehabilitation Research; and the Veteran’s Administration.
Todd Farrell, Director of Research at LTI:
“Our team has always taken pride in conducting innovative research to benefit amputees. Joining Coapt is a perfect match that enables us to propel our research forward with a commercial trailblazer to achieve positive outcomes for prosthetic device users.”
For more information about Coapt, visit www.coaptengineering.com, or visit Coapt on social media via Instagram, Facebook, YouTube, Twitter and LinkedIn. For more information about LTI, visit www.liberatingtech.com.
View Full Press Release.
Coapt makes human-machine interfaces and is the first company with an FDA Class II Cleared product line providing revolutionary and intuitive control technology for advanced prosthetic upper limbs. Founded in 2012 by four leading researchers in the bionics field, Coapt is based on years of research and clinical care. Coapt is an award-winning company that strives to improve the quality of life for prosthesis users by applying clinically dedicated engineering to its portfolio of transformative technologies. For more information, visit www.coaptengineering.com.